Home
/
Orgenesis Inc.
/
Financials
/
Quarterly
Orgenesis Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Orgenesis Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2023
Sep 30, 2023
$110.0K
Apr 15, 2024
Q2
2023
Jun 30, 2023
$113.0K
Apr 15, 2024
Q1
2023
Mar 31, 2023
$142.0K
Apr 15, 2024
Q3
2023
Sep 30, 2022
$7.99M
Apr 15, 2024
Q2
2023
Jun 30, 2022
$7.20M
Apr 15, 2024
Q1
2023
Mar 31, 2022
$7.21M
Apr 15, 2024
Q3
2022
Sep 30, 2021
$8.68M
Nov 10, 2022
Q2
2022
Jun 30, 2021
$10.55M
Aug 15, 2022
Q1
2021
Mar 31, 2021
$9.39M
May 6, 2021
Q3
2021
Sep 30, 2020
$1.73M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$1.75M
Aug 5, 2021
Q1
2021
Mar 31, 2020
$1.88M
May 6, 2021
Q3
2020
Sep 30, 2019
$1.23M
Nov 5, 2020
Q2
2019
Aug 8, 2019
$2.60M
Aug 8, 2019
Q2
2020
Jun 30, 2019
$1.13M
Aug 6, 2020
Q1
2020
Mar 31, 2019
$419.0K
May 8, 2020
Q1
2019
Dec 31, 2018
$1.85M
May 8, 2019
Q3
2019
Aug 31, 2018
$6.23M
Nov 7, 2019
Q2
2019
May 31, 2018
$3.99M
Aug 8, 2019
Q1
2019
Feb 28, 2018
$2.64M
May 8, 2019
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
$347.0K
Nov 13, 2024
Q2
2024
Jun 30, 2024
$246.0K
Aug 8, 2024
Q1
2024
Mar 31, 2024
$141.0K
May 20, 2024
Q3
2024
Sep 30, 2023
$110.0K
Nov 13, 2024
Q2
2024
Jun 30, 2023
$113.0K
Aug 8, 2024
Q1
2024
Mar 31, 2023
$142.0K
May 20, 2024
Q3
2023
Sep 30, 2022
$7.99M
Apr 15, 2024
Q2
2023
Jun 30, 2022
$6.70M
Apr 15, 2024
Q1
2023
Mar 31, 2022
$6.58M
Apr 15, 2024
Q3
2022
Sep 30, 2021
$7.61M
Nov 10, 2022
Q2
2022
Jun 30, 2021
$9.82M
Aug 15, 2022
Q1
2022
Mar 31, 2021
$9.39M
May 23, 2022
Q3
2021
Sep 30, 2020
$1.45M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$1.47M
Aug 5, 2021
Q1
2021
Mar 31, 2020
$1.39M
May 6, 2021
Q3
2020
Sep 30, 2019
$543.0K
Nov 5, 2020
Q2
2020
Jun 30, 2019
$575.0K
Aug 6, 2020
Q1
2020
Mar 31, 2019
$419.0K
May 8, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
($9.12M)
Nov 13, 2024
Q2
2024
Jun 30, 2024
($8.90M)
Aug 8, 2024
Q1
2024
Mar 31, 2024
($9.77M)
May 20, 2024
Q3
2024
Sep 30, 2023
($3.73M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($25.54M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($19.47M)
May 20, 2024
Q3
2023
Sep 30, 2022
($1.36M)
Apr 15, 2024
Q2
2023
Jun 30, 2022
($5.43M)
Apr 15, 2024
Q1
2023
Mar 31, 2022
($4.01M)
Apr 15, 2024
Q3
2022
Sep 30, 2021
($10.16M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($2.66M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($219.0K)
May 23, 2022
Q3
2021
Sep 30, 2020
$2.43M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$20.41M
Aug 5, 2021
Q1
2021
Mar 31, 2020
($69.98M)
May 6, 2021
Q3
2020
Sep 30, 2019
$4.55M
Nov 5, 2020
Q2
2020
Jun 30, 2019
$5.20M
Aug 6, 2020
Q1
2020
Mar 31, 2019
$8.31M
May 8, 2020
Q1
2019
Dec 31, 2018
($2.74M)
May 8, 2019
Q3
2019
Aug 31, 2018
($5.07M)
Nov 7, 2019
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
($8.39M)
Nov 13, 2024
Q2
2024
Jun 30, 2024
($4.25M)
Aug 8, 2024
Q1
2024
Mar 31, 2024
($8.93M)
May 20, 2024
Q3
2024
Sep 30, 2023
($2.24M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($25.07M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($19.60M)
May 20, 2024
Q3
2023
Sep 30, 2022
($281.0K)
Apr 15, 2024
Q2
2023
Jun 30, 2022
($4.73M)
Apr 15, 2024
Q1
2023
Mar 31, 2022
($3.24M)
Apr 15, 2024
Q3
2022
Sep 30, 2021
($7.66M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($2.32M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
$56.0K
May 23, 2022
Q3
2021
Sep 30, 2020
$9.35M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$26.77M
Aug 5, 2021
Q1
2021
Mar 31, 2020
$6.73M
May 6, 2021
Q3
2020
Sep 30, 2019
$3.78M
Nov 5, 2020
Q2
2020
Jun 30, 2019
$4.85M
Aug 6, 2020
Q1
2020
Mar 31, 2019
$8.28M
May 8, 2020
Q1
2019
Dec 31, 2018
($2.96M)
May 8, 2019
Q3
2019
Aug 31, 2018
($645.0K)
Nov 7, 2019